In an anuric end‑stage renal disease patient receiving hemodialysis on Monday, Wednesday, Friday, and Saturday, should the post‑dialysis cefepime dose on Sunday be increased from 1 g to 2 g?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefepime Dosing on Non-Dialysis Days in Hemodialysis Patients

No, you should not increase the Sunday dose to 2 grams—in fact, you should not administer cefepime at all on Sunday. For anuric end-stage renal disease patients receiving hemodialysis four times weekly (Monday, Wednesday, Friday, Saturday), cefepime should be given only immediately after each dialysis session, with no doses on non-dialysis days 1, 2.

Core Dosing Principle for Hemodialysis Patients

The fundamental strategy is to maintain full individual doses while extending the dosing interval, never reducing the milligram amount per administration. 3, 1

  • For severe infections requiring 2 g dosing, administer the full 2 g dose after each dialysis session (four times weekly in your schedule: Monday, Wednesday, Friday, Saturday) 1, 2
  • The interdialytic half-life of cefepime is approximately 22 hours, allowing therapeutic levels to persist between dialysis sessions 2
  • Approximately 68-72% of cefepime is removed during a 3-hour high-flux hemodialysis session 1, 2

Why No Dosing on Sunday

Administering cefepime on non-dialysis days leads to dangerous drug accumulation and neurotoxicity. 4, 5, 6

  • Cefepime is almost exclusively cleared by the kidneys; in anuric patients, there is essentially no elimination between dialysis sessions 1, 4
  • Even with "renal-adjusted" dosing, patients with end-stage renal disease frequently develop cefepime-induced neurotoxicity, manifesting as non-convulsive status epilepticus, delirium, myoclonus, and altered mental status 4, 5, 6
  • The risk of neurotoxicity persists even when doses are adjusted according to manufacturer guidelines, because metabolite accumulation occurs regardless 4, 6

Correct Dosing Schedule for Your Patient

For a patient dialyzed Monday, Wednesday, Friday, and Saturday:

  • Monday: 2 g IV immediately after dialysis 1, 2
  • Tuesday: No dose 1
  • Wednesday: 2 g IV immediately after dialysis 1, 2
  • Thursday: No dose 1
  • Friday: 2 g IV immediately after dialysis 1, 2
  • Saturday: 2 g IV immediately after dialysis 1, 2
  • Sunday: No dose 1

Post-Dialysis Timing is Critical

Always administer cefepime immediately following hemodialysis completion, never before. 1, 3

  • Pre-dialysis administration results in premature drug removal during the dialysis session, leading to subtherapeutic levels and treatment failure 3, 1
  • Post-dialysis administration ensures the full therapeutic dose is retained between sessions 3, 1
  • This timing also facilitates directly observed therapy and improves adherence monitoring 3

Therapeutic Drug Monitoring Considerations

Measure trough cefepime levels immediately before the next dialysis session to verify adequate exposure without excessive accumulation. 2

  • Target trough levels of 20-25 mg/L provide coverage above the MIC₉₀ for most pathogens while minimizing neurotoxicity risk 2
  • Peak levels of 150-170 mg/L are expected immediately after a 2 g dose 2

Common Pitfall to Avoid

The most dangerous error is attempting to "bridge" non-dialysis days with additional doses. This practice invariably leads to drug accumulation and neurotoxicity in anuric patients, even when using reduced doses 4, 5, 6. The extended interdialytic half-life (22 hours) maintains therapeutic levels throughout the 48-72 hour intervals between your patient's dialysis sessions 2.

References

Related Questions

Would you order cefepime (Cefepime) for a patient with end-stage renal disease (ESRD) on dialysis awaiting a CT (Computed Tomography) scan to rule out a periauricular abscess?
Is cefepime (Cefepime) safe to use in patients with impaired renal (kidney) function?
Is a 2g dose of cefepime safe for a patient with impaired renal function, E. coli bacteremia, a suprapubic catheter, and paraplegia?
How to administer Cefepime (Maxipime) 2Gm via a saline lock?
Is Cefepime (Cefepime) 500 mg or 1 gm intramuscularly (IM) suitable for a patient with impaired renal function (dialysis patient)?
What are the current guideline recommendations for managing primary hypertension in adults, including blood pressure targets, lifestyle modifications, first‑line pharmacologic classes, and adjustments for age, race, diabetes, or chronic kidney disease?
What X‑ray views and subsequent management are recommended for an acute traumatic injury to the middle finger with suspected fracture or dislocation?
In an anuric end‑stage renal disease patient receiving hemodialysis on Monday, Wednesday, Friday and Saturday, should an additional cefepime dose be given on Sunday to bridge the three‑day interval before the next dialysis session?
In a patient with a drained intra‑abdominal abscess cultured positive for Enterococcus faecium, who is already receiving ceftazidime‑avibactam, aztreonam, and metronidazole, what are the safety risks of adding vancomycin versus linezolid and which agent is preferred?
In a patient receiving hemodialysis three times per week, how should I schedule and dose antibiotics to maintain therapeutic levels during the two‑day interval between sessions?
In an adult receiving thrice‑weekly intermittent hemodialysis with a session on Monday, what is the appropriate timing and dose of intravenous cefepime?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.